Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013


SMi Pharmacovigilance

01 Jul 2013 - 02 Jul 2013 - London, UK



Bookmark and Share


SMi are proud to present the 3rd annual conference on Pharmacovigilance taking place on 1st & 2nd July 2013, London.

After recent Pharmacovigilance legislations, SMi’s conference will present the successes and failures since its implementation. 2012-2013 can be seen as year of significant change with regards to Pharmacovigilance practices and this topic has never been more of a focus for Pharmaceutical companies across the board.

With concerns occurring across the board in relation to PV auditing, companies face the challenge of understanding the key considerations when presenting to auditors. Unravel the challenges in compiling and presenting the new PSUR to external regulatory bodies and determine what these regulatory bodies have learnt in the wake of its recent introduction.

KEY REASONS TO ATTEND

• Understand the main points to consider when presenting a PSUR to external regulatory bodies.

• Tackle the issues and importance of adverse event reporting.

• Discuss the importance of pharmacoepidemiology and what can be learnt from global trends.

• Assess the benefits and challenges involved with outsourcing pharmacovigilance processes.

• Listen to case studies from companies that have undergone recent pharmacovigilance auditing and what was expected.

Join SMi as they look tackle these issues and many more at a summit that promises to be a must see event.

To Attend contact Jonathan Collins at +44 (0)207 827 6734

Email jcollins@smi-online.co.uk

Register online at http://www.smi-online.co.uk/goto/2013pharmacovigilance19.asp




Further information
Scientific News
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
Drug Design Strategy to Improve Breast Cancer Treatment
Scientists develop novel structure-based drug design strategy aimed at altering the basic landscape of hormone-driven breast cancer treatment.
`Molecular Commando’ Identified to Tackle Hypoxia Pathway
Scientists identify 'molecular commando' that can activate hypoxic response, which helps combat a number of conditions.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Two Antibiotics Fight Bacteria Differently Than Thought
Researchers discover that two widely prescribed antibiotics may fight bacteria differently than previously thought.
Drug Target for Gastrointestinal Stromal Tumors Identified
Researchers show the Hedgehog signaling pathway is central to the formation of gastrointestinal stromal tumors.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!